GLUEMONTE ROSA THERAPEUTICS INC
CUSIP 61225M102 · common stock
3 tracked investors held MONTE ROSA THERAPEUTICS INC (GLUE) at the end of Q3 2026, worth $67.4M in total. The largest holder was Julian Baker, with 0.2% of its portfolio. Stanley Druckenmiller sold out of its position this quarter.
Holders · Q3 2026
3
New holders
0
Value held
$67.4M
Quarter-end price (est.)
$11.93
Investors holding GLUE · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Julian Baker Baker Bros. Advisors LP | 0.25% | 4,345,736 | $51.8M | HOLD |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.51% | 1,007,752 | $12M | ADD+364.9% |
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 295,844 | $3.5M | REDUCE-18.6% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Stanley Druckenmiller | 0.14% | 297,600 | $7.2M | EXIT |